Copenhagen, Denmark

Thomas Boesen

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • København Ø, DK (2015 - 2017)
  • Københan Ø, DK (2017)
  • Københaven Ø, DK (2019)
  • Copenhagen, DK (2008 - 2021)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Thomas Boesen

Introduction

Thomas Boesen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work focuses on developing innovative solutions that enhance the efficacy and solubility of medicinal compounds.

Latest Patents

Among his latest patents is the invention titled "Polymorphs of phenyl pyrrole aminoguandium salts." This patent relates to crystalline forms of N-{3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]-allylidene}-aminoguanidinium salts, which exhibit high solubility. The disclosure emphasizes the potential use of these crystalline forms in medicine. Another significant patent is "Peptide analogues with branched amino acid probe(s)," which involves peptide analogues that comprise one or more branched amino acid probes along with a peptide, either in its native form or as variants.

Career Highlights

Throughout his career, Thomas Boesen has worked with prominent companies in the pharmaceutical industry, including Txp Pharma GmbH and Gilead Sciences, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field.

Collaborations

Thomas has collaborated with several professionals in his field, including Marc A. Labelle and Farman Ullah. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Thomas Boesen's innovative contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new medicinal compounds that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…